Modelling Toxoplasma gondii infection in human cerebral organoids

Emerg Microbes Infect. 2020 Dec;9(1):1943-1954. doi: 10.1080/22221751.2020.1812435.

Abstract

Pluripotent stem cell-derived cerebral organoids have the potential to recapitulate the pathophysiology of in vivo human brain tissue, constituting a valuable resource for modelling brain disorders, including infectious diseases. Toxoplasma gondii, an intracellular protozoan parasite, infects most warm-blooded animals, including humans, causing toxoplasmosis. In immunodeficient patients and pregnant women, infection often results in severe central nervous system disease and fetal miscarriage. However, understanding the molecular pathophysiology of the disease has been challenging due to limited in vitro model systems. Here, we developed a new in vitro model system of T. gondii infection using human brain organoids. We observed that tachyzoites can infect human cerebral organoids and are transformed to bradyzoites and replicate in parasitophorous vacuoles to form cysts, indicating that the T. gondii asexual life cycle is efficiently simulated in the brain organoids. Transcriptomic analysis of T. gondii-infected organoids revealed the activation of the type I interferon immune response against infection. In addition, in brain organoids, T. gondii exhibited a changed transcriptome related to protozoan invasion and replication. This study shows cerebral organoids as physiologically relevant in vitro model systems useful for advancing the understanding of T. gondii infections and host interactions.

Keywords: Cerebral organoid; Toxoplasma gondii; disease modelling; pluripotent stem cells; toxoplasmosis.

MeSH terms

  • Animals
  • Brain / cytology
  • Brain / immunology
  • Brain / parasitology*
  • Cell Line
  • Disease Models, Animal
  • Gene Expression Profiling
  • Gene Regulatory Networks
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Interferon Type I / genetics*
  • Organ Culture Techniques
  • Organoids / cytology
  • Organoids / immunology
  • Organoids / parasitology*
  • Toxoplasma / pathogenicity
  • Toxoplasma / physiology*
  • Toxoplasmosis

Substances

  • Interferon Type I

Grants and funding

This work has been supported by Korea Centers for Disease Control and Prevention (KCDC) grants [grants numbers 2017-NG61004-00, 2017-NC61001-00 and 2017-4837-311].